Teens who feel 'too fat' light up cigarettes to slim down

Among U.S. teens who are frequent smokers, nearly half of girls and one-third of boys smoke to control their weight, according to a new study. Even more common is smoking to lose weight among teens who feel "much too fat."

Gene that drives aggressive prostate cancer identified

An overactive gene appears to cause some prostate cancers to transform from a typical tumor type to a much more aggressive form of the disease, according to new research at Weill Cornell Medicine.

Mabaya is president of African agricultural economists group

Edward Mabaya, M.S. '98, Ph.D. '03, was elected president of the African Association of Agricultural Economists Sept. 23 in Addis Ababa, Ethiopia.

Wildlife program gets $4.8 million to track NYS disease

The New York State Cooperative Wildlife Health Program – a partnership among Cornell and New York state to track and manage wildlife diseases – will receive $4.8 million over the five years.

Freezing technique is effective alternative to lumpectomy

A deep-freezing technique known as cryoablation is a viable alternative to traditional surgery in many early-stage breast cancers according to Weill Cornell Medicine research.

Now is the lightest you will weigh all year

For the average person, the time before the start of the holiday season is the low point in an annual weight gain pattern that peaks during the holidays and takes nearly half a year to fully shed.

Cancer killers: C dots show ability to induce cell death in tumors

Research involving cancer-targeting silica particles, known as Cornell dots, has shown that the particles can neutralize nutrient-deprived cancer cells by a cell-death process called ferroptosis.

$1M expands food safety capabilities at Geneva campus

Cornell’s New York State Agricultural Experiment Station in Geneva is poised to expand its food development and technology commercialization capabilities with $1 million in new state funding.

Researchers develop way to ID diabetes patient-specific drugs

An innovative method that uses human embryonic stem cells to model type 2 diabetes caused by genetic mutations may enable researchers to identify drugs that could treat the disease.